IRIDEX
iOS Universel / Economie et entreprise
IRIDEX is a worldwide leader in developing innovative and versatile laser-based medical systems for the ophthalmology market. The Company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit http://www.iridex.com/.
Quoi de neuf dans la dernière version ?
- Enhanced iOS 17 and iOS 18 Support
- Further support for HTML5 apps.
- Stability fixes and performance improvements.
- Additional bug fixes and improvements.
